硕肯生物硕肯生物Soken.bio
查看试用产品 →开放浏览 · 登录后申请
人 PRSS27 抗体对
试剂盒

人 PRSS27 抗体对

01AB01305

Serine protease 27 (PRSS27), also known as pancreasin, is a secreted tryptic serine protease belonging to the group-1 subfamily of serine proteases and is primarily expressed in the pancreas. The protein is encoded by the PRSS27 gene located within a large protease gene cluster on chromosome 16 and undergoes alternative splicing, resulting in multiple transcript variants. Structurally, PRSS27 is a glycosylated protein with a molecular weight of approximately 30.9 kDa, featuring a signal peptide, propeptide, and mature chain, and contains disulfide bonds critical for its stability and function. Functionally, it is involved in proteolytic processes, and its enzymatic activity is dependent on a conserved serine residue in the active site. Clinically, altered expression of PRSS27 has been identified as a prognostic marker in esophageal squamous cell carcinoma, particularly in patients treated with preoperative chemotherapy.

Human
规格起售价
登录后可查看

技术参数

靶点基因名
PRSS27
基因别名
MPN
蛋白别名
serine protease 27; PRSS27
UniProt
Q9BQR3
物种
Human

产品详情

靶点名称
PRSS27
蛋白名称
serine protease 27
蛋白别名
Serine protease 27; Marapsin; Pancreasin
靶点基因名
PRSS27
基因别名
MPN
UniProt
Q9BQR3
来源物种
Homo sapiens (Human)
物种反应性
Human

背景介绍

Serine protease 27 (PRSS27), also known as pancreasin, is a secreted tryptic serine protease belonging to the group-1 subfamily of serine proteases and is primarily expressed in the pancreas. The protein is encoded by the PRSS27 gene located within a large protease gene cluster on chromosome 16 and undergoes alternative splicing, resulting in multiple transcript variants. Structurally, PRSS27 is a glycosylated protein with a molecular weight of approximately 30.9 kDa, featuring a signal peptide, propeptide, and mature chain, and contains disulfide bonds critical for its stability and function. Functionally, it is involved in proteolytic processes, and its enzymatic activity is dependent on a conserved serine residue in the active site. Clinically, altered expression of PRSS27 has been identified as a prognostic marker in esophageal squamous cell carcinoma, particularly in patients treated with preoperative chemotherapy.